Markets Update Thursday 07/05/2020 – Back and forth

Frankfurt – 07/05/20 Back and forth The international markets still lack orientation. Almost every day, the signs change, and the ups and downs continue. Today, the signs were again predominantly positive, but they too are yet on shaky ground. Once again, miserable economic data from all directions as well as sobering unemployment figures from the USA were hailing. Nevertheless, Mr …

Markets Update Wednesday 06/05/2020 – Another Crisis?

Frankfurt – 06/05/20 Another Crisis? Investors hope for a return to normality in connection with the corona pandemic. For one thing, more and more countries and states are relaxing their restrictions so that the economy can get going again. On the other hand, hopes are growing that a vaccine against the coronavirus or a drug to treat COVID-19, a lung …

Markets Update Tuesday 05/05/2020 – Time to look forward

Frankfurt – 05/05/20 Time to look forward After the big sell-off the last two trading days, Friday and Monday, investors returned to the floor, buying equities on the cheap. Even though the whole picture of the global economy looks as gloomy as can be, investors continue to ignore the hard facts, all profit warnings, recession outlooks, etc. and pump up …

Markets Update Monday 04/05/2020 – Headaches

Frankfurt – 04/05/20 Headaches Following a sobering economic forecast by the ECB and a renewed intensification of the dispute between the USA and China, the hangover could continue at the beginning of the first week of May. It remains to be seen whether important data from the industry will ease or aggravate investors’ headaches. Besides, 9 of the Dax 30 …

Oil price crash: A rough awakening for ETF investors

The situation in the oil market remains tense. The corona crisis is causing demand to fall further, supply is growing, and storage facilities are gradually becoming scarce. Some private investors, who had hoped to profit through the United States Oil Fund from rising oil prices in the future, are now likely to suffer losses. For some time now, oil prices …

Markets Update Thursday 30/04/2020 – The emotional roller-coaster ride continues

Frankfurt – 30/04/20 The emotional roller-coaster ride continues Hopes for economic recovery after the corona crisis gave the stock market a substantial boost in April. Nevertheless, market experts have been warning for weeks against excessive and hasty euphoria. By now it is clear to everyone: the damage caused by the ongoing crisis and the weeks of standstill in the global …

Markets Update Wednesday 29/04/2020 – Buy the hype!?

Frankfurt – 29/04/20 Buy the hype!? This afternoon, Remdesivir was once again the magic word at the global places of illusion – also called stock exchanges… New hopes that the drug from the US biotech company Gilead could bring a breakthrough against the common virus caused a lot of hype and fantasy in the afternoon. Many indices gained considerable momentum …

Markets Update Tuesday 28/04/2020 – Bad news is good news

Frankfurt 28/04/20 Bad news is good news Despite the dim economic outlook, the announcement of further easing from the shutdown is encouraging many investors. On top of this comes the hope of more and more money injections from the government and the expectation of further supporting measures from the central banks in Europe and the USA, which are meeting this …

Markets Update Monday 27/04/2020 – Open up!

Frankfurt – 27/04/20 Open up! Optimism prevailed on the international stock exchanges today. After weeks of stagnation, some countries are cautiously and gradually easing their restrictions in everyday and economic life. For example, more children will soon be able to go back to school or daycare, citizens will be able to do more outdoor sports or visit other people, and …

Markets Update Friday 24/04/2020 – Fail

Frankfurt – 24/04/20 Fail A report on the failure of the Covid-19 hope carrier Remdesivir from Gilead Sciences put a bitter damper on investors. The Financial Times reported that there had been no noticeable improvements in the treatment of patients in China after administration of the drug. The results had been unintentionally made public, and both Gilead and the World …